© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Bullfrog AI Holdings, Inc. Common Stock (BFRG) stock surged +58.33%, trading at $0.95 on NASDAQ, up from the previous close of $0.60. The stock opened at $0.78, fluctuating between $0.71 and $1.05 in the recent session.
| Filing Date | Accepted Date | |
|---|---|---|
| Filing Date | Accepted Date | |
|---|---|---|
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 23, 2026 | 0.78 | 1.05 | 0.71 | 0.95 | 190.97M |
| Sep 21, 2026 | 0.47 | 0.50 | 0.47 | 0.49 | 218.17K |
| Sep 18, 2026 | 0.45 | 0.47 | 0.44 | 0.46 | 66.95K |
| Sep 17, 2026 | 0.43 | 0.47 | 0.43 | 0.47 | 175.59K |
| Sep 16, 2026 | 0.44 | 0.44 | 0.43 | 0.43 | 94.14K |
| Sep 15, 2026 | 0.48 | 0.48 | 0.44 | 0.45 | 87K |
| Sep 14, 2026 | 0.47 | 0.49 | 0.47 | 0.47 | 87.76K |
| Sep 11, 2026 | 0.48 | 0.50 | 0.46 | 0.48 | 65.94K |
| Sep 10, 2026 | 0.48 | 0.51 | 0.47 | 0.49 | 138.29K |
| Sep 09, 2026 | 0.49 | 0.49 | 0.48 | 0.49 | 74.88K |
| Sep 08, 2026 | 0.48 | 0.51 | 0.48 | 0.48 | 86.75K |
| Sep 04, 2026 | 0.51 | 0.51 | 0.49 | 0.50 | 55.66K |
| Sep 03, 2026 | 0.48 | 0.53 | 0.48 | 0.49 | 0 |
| Sep 02, 2026 | 0.50 | 0.50 | 0.48 | 0.49 | 86K |
| Sep 01, 2026 | 0.54 | 0.54 | 0.48 | 0.49 | 250.47K |
| Aug 31, 2026 | 0.53 | 0.57 | 0.51 | 0.54 | 92.92K |
| Aug 28, 2026 | 0.57 | 0.57 | 0.54 | 0.54 | 94.27K |
| Aug 27, 2026 | 0.59 | 0.59 | 0.57 | 0.57 | 37.49K |
| Aug 26, 2026 | 0.58 | 0.59 | 0.56 | 0.57 | 82.6K |
| Aug 25, 2026 | 0.57 | 0.59 | 0.55 | 0.58 | 85.09K |
BullFrog AI Holdings, Inc., along with its affiliated entities, functions as an advanced digital biopharmaceutical firm. Its core mission involves harnessing artificial intelligence and machine learning (AI/ML) to process and interpret extensive medical and healthcare datasets specifically within the United States. A central offering is bfLEAP, a proprietary AI/ML platform meticulously crafted for the thorough examination of both preclinical and clinical research data. The company has also secured critical intellectual property through licensing agreements. One such accord, with George Washington University, provides rights to utilize siRNA targeting Beta2-spectrin. This technology is being investigated for its therapeutic potential across a spectrum of human conditions, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease (NAFLD), and non-alcoholic steatohepatitis (NASH). Additionally, a partnership with Johns Hopkins University grants access to a distinct Mebendazole formulation, developed for the treatment of various human cancers or neoplastic diseases. Founded in 2017, BullFrog AI Holdings, Inc. operates from its headquarters in Gaithersburg, Maryland.
| Employees | 9 |
| Beta | -2.72 |
| Sales or Revenue | $65.00K |
| 5Y Sales Change% | 0% |
| Fiscal Year Ends | December |
| Sector | Healthcare |
| Industry | Medical - Healthcare Information Services |